FDA Adverse Event Malfunction Summary report: N

OMNIPOD INSULIN MANAGEMENT SYSTEM

MDR report key: 7752243 · Received August 6, 2018

Report

Report Number
3004464228-2018-04943
Event Type
Malfunction
Date Received
August 6, 2018
Date of Event
July 8, 2018
Report Date
July 11, 2018
Manufacturer
INSULET CORPORATION
Product Code
LZG
UDI-DI
20385081120033
PMA / PMN Number
K162296
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE WAS NOT RETURNED FOR EVALUATION. WE ARE UNABLE TO CONFIRM THE BENT CANNULA OR TO DETERMINE IF IT COULD HAVE CONTRIBUTED TO THE REPORTED HYPERGLYCEMIA. NO LOT RELEASE RECORDS WERE REVIEWED BECAUSE NO PRODUCT LOT NUMBER WAS REPORTED. OMNIPOD INSULIN MANAGEMENT SYSTEM ¿ USER GUIDE. MODEL: ENT450. 17845-5C-AW REV A 10/17. CHECKING YOUR BLOOD GLUCOSE 4 / PAGE 36. WARNINGS: TEST RESULTS GREATER THAN 13.9 MMOL/L MEAN HIGH BLOOD GLUCOSE (HYPERGLYCEMIA). WARNINGS: IF YOU GET RESULTS BELOW 3.9 MMOL/L OR ABOVE 13.9 MMOL/L, BUT DO NOT HAVE SYMPTOMS OF HYPOGLYCEMIA OR HYPERGLYCEMIA (SEE "LIVING WITH DIABETES" ON PAGE 117), REPEAT THE TEST. IF YOU HAVE SYMPTOMS OR CONTINUE TO GET RESULTS THAT FALL BELOW 3.9 MMOL/L OR ABOVE 13.9 MMOL/L, FOLLOW THE TREATMENT ADVICE OF YOUR HEALTHCARE PROVIDER.

Description of Event or Problem · 1

THE PATIENT'S MOTHER REPORTED HER DAUGHTER'S BLOOD GLUCOSE AND CARBOHYDRATE INTAKE HISTORY IS AS FOLLOWS: TIME BG (MMOL/L) (MG/DL) CHO (G) (B)(6). THE POD WAS DEACTIVATED AND SHE NOTICED THE CANNULA WAS BENT. THE POD WAS WORN LONGER THAN 48 HOURS. HYPERGLYCEMIA TREATED BY PATIENT ACTIVATING NEW POD AND BOLUS. TIME BG (MMOL/L) (MG/DL) CHO (G) (B)(6).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
595500 OMNIPOD INSULIN MANAGEMENT SYSTEM PUMP, INFUSION, INSULIN LZG INSULET CORPORATION 19191 20385081120033

Patients

Seq Age Sex Outcome Treatment
1 12 YR